Special Issue "Dopamine Signaling Pathway in Health and Disease"
Deadline for manuscript submissions: 31 January 2024 | Viewed by 5761
Interests: synaptic plasticity; synaptic transmission; signaling pathways; regulation of gene expression
Interests: neuromodulation; synaptic plasticity; learning and memory; neurodegeneration
Dopamine is a key neurotransmitter modulating multiple and essential physiological functions of the central nervous system, including motor behavior, affective and emotional states, reward and reinforcement behaviors, and other higher cognitive functions. The four major dopaminergic pathways are the nigrostriatal, the mesocortical, the mesolimbic, and the tuberoinfundibular pathway.
Dysfunction in the dopaminergic transmission is recognized as a core alteration in several neurological and psychiatric disorders, including Parkinson’s disease, schizophrenia, bipolar disorder, attention deﬁcit hyperactivity disorder (ADHD), and addiction.
This Special Issue on the “Dopamine Signaling Pathway in Health and Disease” will present a selection of original research papers and reviews concerning the cellular and molecular mechanisms underlying dopaminergic neuromodulation under physiological conditions and in preclinical cellular and animal models of dopaminergic neurodegeneration as well as novel potential pharmacological approaches for dopamine-related disorders.
Prof. Dr. Floriana Volpicelli
Prof. Dr. Maria Concetta Miniaci
Dr. Luisa Speranza
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- disease modeling
- dopamine and drugs
- gene expression
- human stem cells
- neuronal development
- signaling pathways